Menu
_8e29457b-accf-42c4-9828-22c455bc9297

CONTACTLESS IMAGING SYSTEM FOR RAPID VASCULAR ACCESS MONITORING

The fistula is the lifeline that connects a dialysis patient to the dialysis machine. It must be kept clear at all times. For this reason, the fistula must be monitored regularly.

The fistula is the lifeline that connects a dialysis patient to the dialysis machine. It must be kept clear at all times. For this reason, the fistula must be monitored regularly.

There are three major challenges with this:

As dialysis clinics are VERY busy, it’s a challenge for the clinical team to routinely perform proper monitoring.

Direct contact between the patient and the nurse runs the risk of infection and causes pain.

The manual and often painful checks by nurses, that can take around 7-8 minutes, are subjective and require clinical skills rarely available today.

The PatenSee System addresses these challenges with its contactless, optical, fistula monitoring system.

PatenSee’s System

PatenSee’s system simulates the look, listen, feel and the clinical assessment of the patient’s vascular access by the nurses in the dialysis clinic, but non-contact, faster (1 minute rather than 7 minutes) and with data driven, objective, AI learning analyses and reports.

Learn More…

How It Works in a Hemodialysis Clinic

Patient arrives for a dialysis treatment (every 2-3 days).
Patient arrives for a dialysis treatment (every 2-3 days).
x60sec PatenSee imaging (weekly).  Can be done by patient/caretaker in the “waiting room”.
x60sec PatenSee imaging (weekly).  Can be done by patient/caretaker in the “waiting room”.
Real-time data collection and analysis.
Real-time data collection and analysis.
Alert drives referral to IR if needed. Generates info for IR.
Alert drives referral to IR if needed. Generates info for IR.

Contact Us

Info

+972-72-251-3566
Please use form

Address

8 Ariel Sharon St.
Or Yehuda, 6037606. Israel

407 E. Fort Street
Suite 205
Detroit, MI 48226,

Name *
Email *
Subject *
Message

Patensee is limited to investigational use only and is not approved by FDA for sale in the United States

Back To Top
© Patensee 2024
Powered by: SPInc

PatenSee is an emerging, clinical-stage, startup company with a novel, contactless imaging device for the early detection of vascular access complications in hemodialysis patients. The technology uses a unique data stream to mimic a best practice, physical examination. PatenSee recently signed a clinical collaboration agreement with Fresenius Medical Care, following the completion of a POC clinical trial with very promising results.


PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.